The U.S. Strategic National Reserve includes 1.7 million doses of tecovirimat—a smallpox treatment that might also be effective against monkeypox, a rare disease that has been diagnosed in dozens of American and European patients in recent weeks.
The U.S. Strategic National Reserve includes 1.7 million doses of tecovirimat—a smallpox treatment that might also be effective against monkeypox, a rare disease that has been diagnosed in dozens of American and European patients in recent weeks.